NextWave Pharmaceuticals' Acquisition - II

NextWave Pharmaceuticals raised a round of funding on September 25, 2018. Investors include Tris Pharma.

NextWave Pharmaceuticals a specialty pharmaceutical company primarily focused on the development and commercialization of products for the treatment of ADHD and related CNS disorders. NextWave's flags…

Articles about NextWave Pharmaceuticals' Acquisition - II: